About this trial
The study is a multicentric prospective randomised cross-over study. It evaluates the compatibility of patients with the device without altering the routine treatment applied. During this evaluation, either the clinician-adjusted values on the device or the standard pre-set values are used to obtain hourly and 30-minute PVA (Patient Ventilator Asynchrony) recordings. These recordings will be analysed offline to identify the settings used and to compare the hourly and 30-minute PVA (Patient Ventilator Asynchrony) values when synchronisation is automatically set. The relationships and differences between these values will be analysed. For this purpose, the IntelliSync+ option, already available on the device, will be used. This software continuously analyses waveform signals at least a hundred times per second. This allows for the immediate detection of patient efforts and the initiation of inspiration and expiration in real time, thereby replacing traditional trigger settings for inspiration and expiration. If the patient is already synchronised with this option, it will then be possible to switch to traditional synchronisation settings for comparison. Statistical analyses will be conducted using SPSS 24.0, JASP (Just Another Statistical Programme), Jamovi ( fork of JASP), or R software. Initially, all numerical and categorical data will be evaluated using descriptive statistical methods. The distributions of numerical variables will be examined using visual (histograms and probability plots) and analytical methods (Kolmogorov-Smirnov/Shapiro-Wilk tests). Mean/SD (standard deviation) or median/interquartile range (IQR) will be used as measures of distribution. For comparing numerical data that follows a normal distribution, the Student-t test will be used, and for non-normally distributed data, the Mann-Whitney U or Wilcoxon signed-rank tests will be employed. PVA (Patient Ventilator Asynchrony) values will be statistically compared. For the analysis of categorical data, the Chi-Square test will be applied. Bayesian analysis may also be used as necessary during the writing of the study. The results obtained will be interpreted and reported by the researchers. Results with a "p" value below 0.05 will be considered statistically significant.
Eligibility criteria
This trial does not accept healthy volunteersQualifiers
Adult patients older than 18 years of age
Hospitalized at the ICU or emergency department with the intention of treatment with Noninvasive ventilation at least for the upcoming 2 hours with spontaneous breathing activity
Written informed consent signed and dated by the patient or one relative in case that the patient is unable to consent, after full explanation of the study by the investigator and prior to study participation
Disqualifiers
Formalized ethical decision to withhold or withdraw life support
Patient included in another interventional research study under consent
Patient already enrolled in the present study in a previous episode of respiratory failure
Pregnant woman
Trial design
Crossover
Treatments tested in this trial
close-loop synchronization controller with spontaneous mode
Other intervention30 minutes period where the pressure support of spontaneous effort will be automatically titrated based on pressure and flow waveform analysis obtained from the patient during NIV mode.
Conventional
Other intervention30 minutes period where the synchronization of pressure support of patient effort during NIV mode will be manually set.
Treatment groups
Trial outcomes
Primary outcomes
Asynchrony Index
\[(detectable asynchronies )/(total number of breaths + ineffective efforts)\]x100
Secondary outcomes
Major Asynchrony index
\[(major asynchronies)/(total number of breaths + ineffective efforts)\]x100
Minor Asynchrony index
\[(minor asynchronies)/(total number of breaths + ineffective efforts)\]x100
Dyspnea Scale
Patient subjective dyspnea scale
Sponsors and contacts
Click on the lead sponsor to view all of their trials.